生物活性化合物和益生菌-在COVID-19管理中的希望之光
Indu Bhushan1, Mahima Sharma1, Malvika Mehta1
1School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.
生物活性化合物和益生菌在治疗病毒性疾病,特别是呼吸道感染方面表现有前途. 这些药物可以增强免疫力,并为COVID-19管理提供一种有希望的方法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物活性化合物和益生菌在治疗病毒性疾病方面有着悠久的使用历史.
- 这些药物具有与呼吸道病毒感染相关的抗病毒,抗炎和抗过敏特性.
研究的目的:
- 审查生物活性化合物和益生菌在增强对病毒性疾病免疫力的重要性.
- 突出在COVID-19管理的背景下潜在的应用.
主要方法:
- 对生物活性化合物和益生菌现有研究的文献综述.
- 对它们与病毒感染和免疫增强相关的特性进行分析.
主要成果:
- 生物活性化合物和益生菌细菌显示出对抗病毒感染的潜力.
- 它们的抗病毒,抗炎和抗过敏作用对于免疫支持至关重要.
结论:
- 生物活性化合物和益生菌是支持免疫系统的有希望的途径.
- 这些天然剂为包括COVID-19在内的病毒性疾病的管理提供了一个有希望的策略.
更多相关视频
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
05:45Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
相关概念视频
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
COPD: Management Using Bronchodilators and Corticosteroids
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
